Planned phase I trial of PAN 622 in hepatocellular carcinoma
Phase of Trial: Phase I
Latest Information Update: 07 Dec 2007
At a glance
- Drugs PAN 622 (Primary)
- Indications Liver cancer
- Focus Adverse reactions
- 07 Dec 2007 This trial is expected to begin in early 2009.
- 07 Dec 2007 New trial record.